clinical trials for glp 1 Continued growth GLP-1 receptor agonists and SGLT-2 inhibitors in 2017 Clinical efficacy results from clinical

Current research is examining whether GLP-1 therapy can modify the trajectory of autoimmune diseases by addressing the metabolic dysfunction that amplifies immune dysregulation

The company recently trialed an oral semaglutide in people with Alzheimers disease who had mild cognitive impairment or mild dementia

When you look at the trials, most trials either exclude older adults, or if they include them, very few are over the age of 65, and even fewer are over the age of 75, Batsis said

This will increase compliance and therefore the effectiveness of the treatment for millions of patients

GLP-1 medications, including Mounjaro (Tirzepatide) and Semaglutide, require a medical evaluation and are not suitable for everyone